SB 353 Maryland Senate · 2022 Regular Session

Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

Bill status vetoed 4 of 5 stages cleared

Introduction

Jan 2022

Committee Review

Mar 2022

Senate Passage

Mar 2022

House of Delegates Passage

Mar 2022

Vetoed

May 2022

Introduced Jan 21, 2022 Vetoed May 27, 2022

Floor votes · Senate Feb 28, 2022 · House of Delegates Mar 24, 2022

How they voted

38–0

Passed

Total votes 38

Feb 28, 2022

D Democratic24

24 Yea

100% Yea

R Republican14

14 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

May 27, 2022

Vetoed

Vetoed by the Governor (Duplicative)

executive

Mar 31, 2022

Upper · Passed

Returned Passed

upper

Mar 31, 2022

Lower · Passed

Third Reading Passed

lower

Mar 30, 2022

Lower · Passed

Favorable Adopted Second Reading Passed

lower

Mar 30, 2022

Lower · Passed

Favorable Report by Health and Government Operations

lower

Mar 24, 2022

House Of Delegates · Passed

House of Delegates Vote: pass (107-0-14)

house of delegates

Mar 11, 2022

Committee

Referred Health and Government Operations

lower

Mar 10, 2022

Upper · Passed

Third Reading Passed

upper

Mar 8, 2022

Upper · Passed

Favorable with Amendments {

upper

Mar 7, 2022

Upper · Passed

Favorable with Amendments Report by Finance

upper

Feb 28, 2022

Senate · Passed

Senate Vote: pass (38-0)

senate

Jan 21, 2022

Committee

First Reading Finance

upper

11 primary · 0 co-sponsors